Linezolid-Resistant Staphylococcus epidermidis, Portugal, 2012.
作者信息
Barros Mariana, Branquinho Raquel, Grosso Filipa, Peixe Luísa, Novais Carla
出版信息
Emerg Infect Dis. 2014 May;20(5):903-5. doi: 10.3201/eid2005.130783.
Abstract
摘要
相似文献
1
Linezolid-Resistant Staphylococcus epidermidis, Portugal, 2012.
Emerg Infect Dis. 2014 May;20(5):903-5. doi: 10.3201/eid2005.130783.
2
Molecular epidemiology of Staphylococcus epidermidis clinical isolates from U.S. hospitals.
Antimicrob Agents Chemother. 2012 Sep;56(9):4656-61. doi: 10.1128/AAC.00279-12. Epub 2012 Jun 11.
3
Endemic linezolid-resistant Staphylococcus epidermidis in a critical care unit.
Eur J Clin Microbiol Infect Dis. 2009 May;28(5):527-33. doi: 10.1007/s10096-008-0657-5. Epub 2008 Nov 5.
4
Molecular and epidemiologic characteristics of linezolid-resistant coagulase-negative staphylococci at a tertiary care hospital.
Diagn Microbiol Infect Dis. 2010 Sep;68(1):34-9. doi: 10.1016/j.diagmicrobio.2010.05.007.
5
Use of pyrosequencing to identify point mutations in domain V of 23S rRNA genes of linezolid-resistant Staphylococcus aureus and Staphylococcus epidermidis.
Eur J Clin Microbiol Infect Dis. 2007 Mar;26(3):161-5. doi: 10.1007/s10096-007-0261-0.
6
Dissemination of the linezolid-resistant Staphylococcus epidermidis clone ST2 exhibiting the G2576T mutation in the 23S rRNA gene in a tertiary-care hospital, Brazil.
J Antimicrob Chemother. 2012 Mar;67(3):768-9. doi: 10.1093/jac/dkr538. Epub 2011 Dec 20.
7
Dissemination of two international linezolid-resistant Staphylococcus epidermidis clones in Greek hospitals.
J Antimicrob Chemother. 2010 May;65(5):1070-1. doi: 10.1093/jac/dkq065. Epub 2010 Mar 5.
8
First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States.
Antimicrob Agents Chemother. 2008 Jun;52(6):2244-6. doi: 10.1128/AAC.00231-08. Epub 2008 Apr 7.
9
Nosocomial outbreak of methicillin- and linezolid-resistant Staphylococcus epidermidis associated with catheter-related infections in intensive care unit patients.
Int J Med Microbiol. 2011 Apr;301(4):354-8. doi: 10.1016/j.ijmm.2010.11.001. Epub 2011 Jan 14.
10
Linezolid resistance in Staphylococcus epidermidis associated with a G2603T mutation in the 23S rRNA gene.
Int J Antimicrob Agents. 2009 Sep;34(3):281-2. doi: 10.1016/j.ijantimicag.2009.02.023. Epub 2009 Apr 18.
引用本文的文献
1
The pathogenicity and virulence of the opportunistic pathogen .
Virulence. 2024 Dec;15(1):2359483. doi: 10.1080/21505594.2024.2359483. Epub 2024 Jun 13.
2
Highly Synergistic Effects of Melittin With Vancomycin and Rifampin Against Vancomycin and Rifampin Resistant .
Front Microbiol. 2022 Jun 23;13:869650. doi: 10.3389/fmicb.2022.869650. eCollection 2022.
3
Emergence of linezolid-resistant Staphylococcus epidermidis in the tertiary children's hospital in Cracow, Poland.
Eur J Clin Microbiol Infect Dis. 2020 Sep;39(9):1717-1725. doi: 10.1007/s10096-020-03893-w. Epub 2020 Apr 29.
4
A New Bioactive Compound From the Marine Sponge-Derived sp. SBT348 Inhibits Staphylococcal Growth and Biofilm Formation.
Front Microbiol. 2018 Jul 11;9:1473. doi: 10.3389/fmicb.2018.01473. eCollection 2018.
5
Marine Sponge-Derived sp. SBT343 Extract Inhibits Staphylococcal Biofilm Formation.
Front Microbiol. 2017 Feb 16;8:236. doi: 10.3389/fmicb.2017.00236. eCollection 2017.
6
In Vitro and In Vivo Activities of a Bi-Aryl Oxazolidinone, RBx 11760, against Gram-Positive Bacteria.
Antimicrob Agents Chemother. 2016 Nov 21;60(12):7134-7145. doi: 10.1128/AAC.00453-16. Print 2016 Dec.
7
Oritavancin Activity Tested against Molecularly Characterized Staphylococci and Enterococci Displaying Elevated Linezolid MIC Results.
Antimicrob Agents Chemother. 2016 May 23;60(6):3817-20. doi: 10.1128/AAC.00281-16. Print 2016 Jun.
8
Mutations in the bacterial ribosomal protein l3 and their association with antibiotic resistance.
Antimicrob Agents Chemother. 2015;59(6):3518-28. doi: 10.1128/AAC.00179-15. Epub 2015 Apr 6.
本文引用的文献
1
Molecular epidemiology of Staphylococcus epidermidis clinical isolates from U.S. hospitals.
Antimicrob Agents Chemother. 2012 Sep;56(9):4656-61. doi: 10.1128/AAC.00279-12. Epub 2012 Jun 11.
2
Characterization of globally spread Escherichia coli ST131 isolates (1991 to 2010).
Antimicrob Agents Chemother. 2012 Jul;56(7):3973-6. doi: 10.1128/AAC.00475-12. Epub 2012 Apr 9.
3
Strategies of adaptation of Staphylococcus epidermidis to hospital and community: amplification and diversification of SCCmec.
J Antimicrob Chemother. 2012 Jun;67(6):1333-41. doi: 10.1093/jac/dks068. Epub 2012 Mar 15.
4
Dissemination of the linezolid-resistant Staphylococcus epidermidis clone ST2 exhibiting the G2576T mutation in the 23S rRNA gene in a tertiary-care hospital, Brazil.
J Antimicrob Chemother. 2012 Mar;67(3):768-9. doi: 10.1093/jac/dkr538. Epub 2011 Dec 20.
5
Dissemination of two international linezolid-resistant Staphylococcus epidermidis clones in Greek hospitals.
J Antimicrob Chemother. 2010 May;65(5):1070-1. doi: 10.1093/jac/dkq065. Epub 2010 Mar 5.
6
Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700).
Antimicrob Agents Chemother. 2009 Dec;53(12):5265-74. doi: 10.1128/AAC.00871-09. Epub 2009 Sep 14.
7
Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid.
Mol Microbiol. 2007 Jun;64(6):1506-14. doi: 10.1111/j.1365-2958.2007.05744.x.
8
Distribution of florfenicol resistance genes fexA and cfr among chloramphenicol-resistant Staphylococcus isolates.
Antimicrob Agents Chemother. 2006 Apr;50(4):1156-63. doi: 10.1128/AAC.50.4.1156-1163.2006.
Zotero 插件